UK life sciences

R&D

The UK life sciences sector at a crossroads: Bold decisions ...

We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.

Market Access

Health, growth & renewal: ABPI 2026 looks to UK’s future

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

News

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele...

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.

R&D

Why the government’s latest funding push is critical to the ...

Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa

R&D

Knowledge Quarter, King's Cross, London, UK

From physics to pharma: How Aqemia is reinventing the future...

The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.

R&D